search

Active clinical trials for "Heart Diseases"

Results 1881-1890 of 3529

Optical Coherence Tomography Assessment of Intimal Tissue and Malapposition

Coronary Heart Disease

The purpose of this study is to use a high-resolution intracoronary imaging modality, called optical coherence tomography (OCT) to examine two different types of coronary artery stents used to treat patients with coronary artery disease.

Unknown status12 enrollment criteria

Data Collection and Analysis of Patients Who Have Had an Electrophysiological Procedure

Heart DiseaseAtrial Fibrillation

The purpose of the database is to complete outcomes research of electrophysiological procedures.

Terminated4 enrollment criteria

Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)

ArteriosclerosisHypertension1 more

GENOA, the Genetic Epidemiology Network of Arteriopathy, consists of a network of three field centers and biochemical and genetic core labs to study the common polymorphic genetic variations to determine individual differences in blood pressure and essential hypertension in 1,500 sibling pairs in three racial groups. Linkage analyses are performed using an extensive array of candidate genes and anonymous markers throughout the genome.

Terminated2 enrollment criteria

Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial

Coronary Heart Disease

The experimental design is a multi-center, prospective, non-controlled, non-randomized, single-arm clinical registry trial. The study will enroll 5,000 patients who receive the Firebird2TM Cobalt-ChromiumAlloyed Sirolimus-Eluting Stent implantation. For patient with multivessel disease, only Firebird 2TM Stent will be implanted. The enrollment of patients will take about 4 months. Clinical follow-up will be at 30 day, 6 month, 12 month, 24 month and 36 month. Patients withdrawing the study due to any reasons will not be replaced.

Unknown status9 enrollment criteria

Congenital Heart Disease Research Registry

Congenital Heart Disease

The Congenital Heart Disease Research Registry (CHDRR) is a program dedicated to understanding the etiology and improving the treatment of Congenital Heart Disease (CHD). This Registry will act as a central coordinating center for recruiting subjects with CHD and will provide infrastructure and guidelines for researchers studying the causes and treatment of CHD. Investigators working directly with the Registry will have access to biological, demographic and phenotype data from a significant pool of participants with CHD.

Terminated3 enrollment criteria

Revascularization in Heart Failure Trial - REHEAT 2

Left Ventricular Ejection FractionMyocardial Revascularization1 more

REHEAT 2 study is designed as a prospective, randomised trial comparing two strategies of myocardial revascularisation (PCI vs CABG) in patients with ischemic cardiomyopathy and low left ventricular ejection fraction.Patients will undergo in random way PCI or CABG procedure. The aim the study is to assess the improvement of left ventricle systolic function and comparing recent (30 days) and late (12 months) results of surgical (CABG) and percutaneous (PCI) revascularization.

Unknown status21 enrollment criteria

Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan

Left Atrial VolumeHypertensive Heart Disease3 more

Aim of the study is to compare in hypertensive patients the effect of one year therapy with ACE-inhibitor (RAMIPRIL) or angiotensin II receptor blocker (IRBESARTAN) on left atrial remodelling and diastolic function.

Unknown status10 enrollment criteria

A Morbidity-Mortality and Remodeling Study With Valsartan

HypertensionIschemic Heart Disease1 more

The JIKEI HEART Study has been designed to investigate whether concomitant treatment with valsartan, an angiotensin II receptor blocker (ARB), in addition to conventional treatment, will improve the prognosis of 3000 Japanese patients with cardiovascular diseases.

Unknown status5 enrollment criteria

Effect of Pravastatin on Endothelial Dysfunction Following a Single High Fat Meal

Heart Diseases

There is significant evidence that HMG-CoA reductase inhibitors, a commonly used class of cholesterol lowering medications, reduce the risk of death from coronary disease. Although these medicines lower cholesterol levels, other studies suggest that they have an additional effect on improving blood vessel functioning. It has also been shown that consumption of a fatty meal temporarily alters blood vessel functioning, causing endothelial dysfunction. This study will examine if pravastatin, an HMG-CoA reductase inhibitor, improves blood vessel functioning after a fatty meal. We plan on enrolling 32 subjects, aged 18-40 years, who are healthy with no history of diabetes, smoking, high blood pressure, or heart disease. These subjects will be randomly assigned to initially receive four days of pravastatin or an inactive substance, and then crossed over to the other group. Blood vessel functioning will be monitored by a technique called flow mediated vasoactivity, which uses ultrasound measurement of the forearm artery and its response to temporary occlusion. This primary measure of flow mediated vasoactivity will be done before and after consumption of a fatty meal. We hope to show that treatment with pravastatin prevents the blood vessel dysfunction known to occur after a high fat meal. Secondary outcomes will include measurement of endothelin-l, a mediator of blood vessel functioning, and assessment of changes in lipid profiles. If pravastatin does prevent endothelial dysfunction in this setting, it could lead to further studies about their use in more acute medical settings, including heart attacks or strokes.

Unknown status1 enrollment criteria

Effect of Thiamin Supplementation on Thiamin Status in Children With Heart Disease Receiving Diuretic...

Heart Diseases

The purpose of this study is to determine effect of thiamin supplementation on thiamin status by measuring thiamin pyrophosphate effect in children with heart disease receiving diuretic drugs.

Unknown status8 enrollment criteria
1...188189190...353

Need Help? Contact our team!


We'll reach out to this number within 24 hrs